Back to Report Store Home

Osteoporosis Therapeutics in Asia-Pacific Markets to 2024 – Growth Driven by ongoing Transition from Anti-resorptive Agents to Anabolic Therapies, Rising Prevalence, and Growing Awareness

  • Published: Jul-2018
  • Report Code: GBIHC478MR
  • Report Format: pdf

Description

List of Figures

Figure 1: Osteoporosis Therapeutics Market, Indian Osteoporosis Treatment Guidelines, 2013 21

Figure 2: Osteoporosis Therapeutics Market, Treatment Algorithm of Osteoporosis 23

Figure 3: Osteoporosis Therapeutics Market, Comparative Efficacy and Safety Heat Map for Marketed Products for the Treatment of Osteoporosis, 2018 44

Figure 4: Osteoporosis Therapeutics Market, Comparative Efficacy Heat Map for Marketed Products for the Treatment of Osteoporosis in Men, 2018 44

Figure 5: Osteoporosis Therapeutics Market, Comparative Efficacy Heat Map for Marketed Products for the Treatment of Glucocorticoid-Induced Osteoporosis, 2018 45

Figure 6: Osteoporosis Therapeutics Market, Comparative Efficacy Heat Map for Marketed Products for the Prevention of Osteoporosis in Postmenopausal Women, 2018 45

Figure 7: Pipeline for Osteoporosis Therapeutics, Global, 2018 48

Figure 8: Pipeline for Osteoporosis Therapeutics by Molecular Target, Global, 2018 51

Figure 9: Pipeline for Osteoporosis Therapeutics by Molecular Target and Stage of Development, Global, 2018 52

Figure 10: Osteoporosis Therapeutics Market, Asia-Pacific, Romosozumab Market Forecast ($m), 2018–2022 55

Figure 11: Osteoporosis Therapeutics Market, Asia-Pacific, Abaloparatide Market Forecast ($m), 2018–2024 58

Figure 12: Osteoporosis Therapeutics Market, Asia-Pacific, Uni-PTH Market Forecast ($m), 2019–2024 59

Figure 13: Osteoporosis Therapeutics Market, Comparative Efficacy Heat Map for Pipeline Products, 2018 60

Figure 14: Osteoporosis Therapeutics Market, Global, Competitor Matrix for Marketed and Pipeline Products, 2018 62

Figure 15: Osteoporosis Therapeutics, Global, Average Clinical Trial Failure Rate (%), 2006–2017 64

Figure 16: Osteoporosis Therapeutics, Global, Clinical Trial Failure Rates by Molecule Type (%), 2006–2017 65

Figure 17: Osteoporosis Therapeutics, Global, Clinical Trial Failure Rates by Molecular Target (%), 2006–2017 66

Figure 18: Osteoporosis Therapeutics, Global, Clinical Trial Duration by Molecule Type, 2006–2017 67

Figure 19: Osteoporosis Therapeutics, Global, Clinical Trial Duration by Molecular Target, 2006–2017 68

Figure 20: Osteoporosis Therapeutics, Global, Clinical Trial Size per Product by Molecule Type, 2006–2017 69

Figure 21: Osteoporosis Therapeutics, Global, Clinical Trial Size per Product by Molecular Target, 2006–2017 70

Figure 22: Osteoporosis Therapeutics, Global, Clinical Trial Size per Trial by Molecule Type, 2006–2017 71

Figure 23: Osteoporosis Therapeutics, Global, Clinical Trial Size per Trial by Molecular Target, 2006–2017 72

Figure 24: Osteoporosis Therapeutics Market, Global, Comparison of Average Trial Metrics by Phase and Molecule Type 73

Figure 25: Osteoporosis Therapeutics Market, Global, Comparison of Average Trial Metrics by Phase and Molecular Target 73

Figure 26: Osteoporosis Therapeutics Market, Asia-Pacific, Treatment Patterns (million) and Market Size ($bn), 2017–2024 75

Figure 27: Osteoporosis Therapeutics Market, India, Treatment Patterns (million), 2017–2024 77

Figure 28: Osteoporosis Therapeutics Market, India, Annual Cost of Therapy ($), 2017–2024 78

Figure 29: Osteoporosis Therapeutics Market, India, Market Size ($m), 2017–2024 79

Figure 30: Osteoporosis Therapeutics Market, China, Treatment Patterns (million), 2017–2024 81

Figure 31: Osteoporosis Therapeutics Market, China, Annual Cost of Therapy ($), 2017–2024 82

Figure 32: Osteoporosis Therapeutics Market, China, Market Size ($m), 2017–2024 83

Figure 33: Osteoporosis Therapeutics Market, Australia, Treatment Patterns (‘000), 2017–2024 85

Figure 34: Osteoporosis Therapeutics Market, Australia, Annual Cost of Therapy ($), 2017–2024 86

Figure 35: Osteoporosis Therapeutics Market, Australia, Market Size ($m), 2017–2024 87

Figure 36: Osteoporosis Therapeutics Market, South Korea, Treatment Patterns (‘000), 2017–2024 89

Figure 37: Osteoporosis Therapeutics Market, South Korea, Annual Cost of Therapy ($), 2017–2024 90

Figure 38: Osteoporosis Therapeutics Market, South Korea, Market Size ($m), 2017–2024 91

Figure 39: Osteoporosis Therapeutics Market, Japan, Treatment Patterns (million), 2017–2024 93

Figure 40: Osteoporosis Therapeutics Market, Japan, Annual Cost of Therapy ($), 2017–2024 94

Figure 41: Osteoporosis Therapeutics Market, Japan, Market Size ($m), 2017–2024 95

Figure 42: Osteoporosis Therapeutics Market, Global, Licensing Deals by Region and Value, 2006–2017 100

Figure 43: Osteoporosis Therapeutics Market, Global, Number of Disclosed and Undisclosed Licensing Deals by Year, Aggregate Deal Value and Aggregate Upfront Payment Value, 2006–2017 101

Figure 44: Osteoporosis Therapeutics Market, Global, Licensing Deals by Stage of Development, Deal Value and Upfront Payment Value, 2006–2017 102

Figure 45: Osteoporosis Therapeutics Market, Global, Licensing Deals by Molecule Type and Stage of Development, 2006–2017 103

Figure 46: Osteoporosis Therapeutics Market, Global, Licensing Deals by Molecular Targets and Aggregate Deal Value ($), 2006–2017 103

Figure 47: Osteoporosis Therapeutics Market, Global, Co-development Deals by Region, 2006–2017 106

Figure 48: Osteoporosis Therapeutics Market, Global, Number of Disclosed and Undisclosed Co-development Deals by Year, Aggregate Deal Value and Aggregate Upfront Payment Value, 2006–2017 106

Figure 49: Osteoporosis Therapeutics Market, Global, Co-development Deals by Stage of Development, Deal Value and Upfront Payment Value, 2006–2017 107

Figure 50: Osteoporosis Therapeutics Market, Global, Co-development Deals by Molecule Type and Stage of Development, 2006–2017 108

Figure 51: Osteoporosis Therapeutics Market, Global, Co-development Deals by Molecular Target, 2006–2017 108

 
      captcha refresh

I have read and accept terms and conditions and privacy policy

Cancel
License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$4995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$9990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$14985
Email to a colleague Request Sample Pages Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards